Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prateek C Gandiga

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Rheumatology|May 18, 2026
Chimeric antigen receptor T-cell (CAR-T) therapy and other cellular immunotherapy treatments for idiopathic inflammatory myopathiesJisna R Paul, Prateek C Gandiga, Rohit Aggarwal
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 24, 2006
Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulationPrateek C Gandiga, Friedhelm C Hummel, Leonardo G Cohen
Current Rheumatology Reports|June 1, 2023
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical UsePrateek C Gandiga, Daniela Ghetie, Elizabeth Anderson, et al.
JACC. Case Reports|July 28, 2021
New-Onset Uncontrolled Hypertension and Renal Failure in a Young WomanKatharine Rainer, Parham Eshtehardi, Zachary L Bercu, et al.
Autoimmunity Reviews|July 16, 2025
Remission and low disease activity definitions in adult idiopathic inflammatory myopathies: A narrative review by myositis clinical trials consortium (MCTC)Nantakarn Pongtarakulpanit, Shiri Keret, Vaidehi Kothari, et al.
Clinical and Experimental Rheumatology|February 25, 2026
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trialsDaphne Rivero Gallegos, Faye M Pais, Ting-Yuan Lan, et al.
Clinical and Experimental Rheumatology|February 20, 2025
The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositisAnuradha Bishnoi, Iris Yan Ki Tang, Akira Yoshida, et al.
The New England Journal of Medicine|March 30, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Rheumatology|May 18, 2026
Chimeric antigen receptor T-cell (CAR-T) therapy and other cellular immunotherapy treatments for idiopathic inflammatory myopathiesJisna R Paul, Prateek C Gandiga, Rohit Aggarwal
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 24, 2006
Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulationPrateek C Gandiga, Friedhelm C Hummel, Leonardo G Cohen
Current Rheumatology Reports|June 1, 2023
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical UsePrateek C Gandiga, Daniela Ghetie, Elizabeth Anderson, et al.
JACC. Case Reports|July 28, 2021
New-Onset Uncontrolled Hypertension and Renal Failure in a Young WomanKatharine Rainer, Parham Eshtehardi, Zachary L Bercu, et al.
Autoimmunity Reviews|July 16, 2025
Remission and low disease activity definitions in adult idiopathic inflammatory myopathies: A narrative review by myositis clinical trials consortium (MCTC)Nantakarn Pongtarakulpanit, Shiri Keret, Vaidehi Kothari, et al.
Clinical and Experimental Rheumatology|February 25, 2026
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trialsDaphne Rivero Gallegos, Faye M Pais, Ting-Yuan Lan, et al.
Clinical and Experimental Rheumatology|February 20, 2025
The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositisAnuradha Bishnoi, Iris Yan Ki Tang, Akira Yoshida, et al.
The New England Journal of Medicine|March 30, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
Pageof 1